methyl 2-(N-(tert-butoxycarbonyl)aminomethyl)phenylacetate | 147410-31-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 2-(N-(tert-butoxycarbonyl)aminomethyl)phenylacetate
• 英文别名: [2-(tert-butoxycarbonylamino-methyl)-phenyl]-acetic acid methyl ester；Tert-butyl 2-((methoxycarbonyl)methyl)benzylcarbamate；methyl 2-[2-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]phenyl]acetate
• CAS: 147410-31-9
• 化学式: C₁₅H₂₁NO₄
• 分子量: 279.336
• InChiKey: QGIIJVCXDSQLMQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  20
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  64.6
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  methyl 2-(N-(tert-butoxycarbonyl)aminomethyl)phenylacetate 在 盐酸 、 lithium hydroxide 、 O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate 、 三乙胺 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 、 甲醇 、 乙醚 、 二氯甲烷 、 乙腈 为溶剂， 生成 2-[2-(methanesulfonylamino-methyl)-phenyl]-N-methyl-N-[1-(S)-phenyl-2-pyrrolidin-1-yl-ethyl]-acetamide
  参考文献：
  名称：

  Arylacetamide κ opioid receptor agonists with reduced cytochrome P450 2D6 inhibitory activity

  摘要：

  Some K opioid receptor agonists of the arylacetamide class, for example, ICI 199441 (1), were found to strongly inhibit the activity of cytochrome P450 2D6 (CYP2D6) (1: CYP2D6 IC50 = 26 nM). Certain analogs bearing a substituted sulfonylamino group, for example, 13, were discovered to have significantly reduced CYP2D6 inhibitory activity (13: CYP2D6 IC50 > 10 mu M) while displaying high affinity toward the cloned human K opioid receptor, good kappa/delta and kappa/mu selectivity, and potent in vitro and in vivo agonist activity. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.03.020
• 作为产物：
  描述：

  (2-氰基苯基)乙酸甲酯 在 palladium on activated charcoal 盐酸 、 氢气 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 25.0 ℃ 、482.63 kPa 条件下， 生成 methyl 2-(N-(tert-butoxycarbonyl)aminomethyl)phenylacetate
  参考文献：
  名称：

  Arylacetamide κ opioid receptor agonists with reduced cytochrome P450 2D6 inhibitory activity

  摘要：

  Some K opioid receptor agonists of the arylacetamide class, for example, ICI 199441 (1), were found to strongly inhibit the activity of cytochrome P450 2D6 (CYP2D6) (1: CYP2D6 IC50 = 26 nM). Certain analogs bearing a substituted sulfonylamino group, for example, 13, were discovered to have significantly reduced CYP2D6 inhibitory activity (13: CYP2D6 IC50 > 10 mu M) while displaying high affinity toward the cloned human K opioid receptor, good kappa/delta and kappa/mu selectivity, and potent in vitro and in vivo agonist activity. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.03.020

文献信息

• Sulfonylamino phenylacetamide derivatives and methods of their use
  申请人：——

  公开号：US20040254156A1

  公开（公告）日：2004-12-16

  Sulfonylamino phenylacetamide derivatives of the general formula 1 are disclosed. Pharmaceutical compositions containing the compounds and methods for their use are also disclosed. In certain embodiments, the compounds of the invention that, preferably: (1) bind with high affinity to &kgr; opioid receptors; (2) display good opioid receptor selectivity of &kgr; versus &mgr; and &kgr; versus &dgr;; and (3) do not substantially inhibit cytochrome P450 enzymatic activity, in particular CYP2D6, CYP2C9 and CYP3A4.

  揭示了通式1的磺酰氨基苯乙酰胺衍生物。还公开了含有这些化合物的药物组合物和它们的使用方法。在某些实施例中，本发明的化合物最好具有以下特征：(1) 与κ阿片受体结合的亲和力高；(2) 在κ与μ受体以及κ与δ受体之间显示良好的阿片受体选择性；以及(3) 不显著抑制细胞色素P450酶的活性，特别是CYP2D6、CYP2C9和CYP3A4。
• Effects of remote N-(tert-butoxycarbonyl) groups on heteroatom directed lithiation at benzylic positions
  作者：Robin D. Clark、Jahangir

  DOI：10.1016/s0040-4020(01)90188-7

  日期：1993.2

  Lithiation of N-BOC-2-methylphenethylamine (6) occurs exclusively at the methyl group whereas lithiation of the phenylpropyl congener (11) is less regioselective. N-BOC-phenylpropylamine (17) is efficiently lithiated at the benzylic position while N-BOC-2-methylphenylbutylamine (23) undergoes lithiation of the methyl group but with low conversion. The results are discussed from the general perspective

  N -BOC -2-甲基苯乙胺（6）的锂化仅发生在甲基上，而苯丙基同类物（11）的锂化具有较低的区域选择性。N -BOC-苯基丙胺（17）在苄基位置上被有效地锂化，而N -BOC-2-甲基苯基丁胺（23）经历甲基的锂化但转化率低。从杂原子定向金属化的一般角度讨论了结果。几种硫代衍生物可以转化为杂环，例如四氢-3-苯并ze庚因-2-酮（10），六氢-3-苯并偶氮星-2-酮（16）和3-苯基吡咯烷酮（19-22）。
• US6992193B2
  申请人：——

  公开号：US6992193B2

  公开（公告）日：2006-01-31
• Arylacetamide κ opioid receptor agonists with reduced cytochrome P450 2D6 inhibitory activity
  作者：Bertrand Le Bourdonnec、Christopher W. Ajello、Pamela R. Seida、Roberta G. Susnow、Joel A. Cassel、Serge Belanger、Gabriel J. Stabley、Robert N. DeHaven、Diane L. DeHaven-Hudkins、Roland E. Dolle

  DOI：10.1016/j.bmcl.2005.03.020

  日期：2005.5

  Some K opioid receptor agonists of the arylacetamide class, for example, ICI 199441 (1), were found to strongly inhibit the activity of cytochrome P450 2D6 (CYP2D6) (1: CYP2D6 IC50 = 26 nM). Certain analogs bearing a substituted sulfonylamino group, for example, 13, were discovered to have significantly reduced CYP2D6 inhibitory activity (13: CYP2D6 IC50 > 10 mu M) while displaying high affinity toward the cloned human K opioid receptor, good kappa/delta and kappa/mu selectivity, and potent in vitro and in vivo agonist activity. (c) 2005 Elsevier Ltd. All rights reserved.